跳至主要内容
临床试验/NL-OMON52454
NL-OMON52454招募中不适用

The effects of antipsychotic maintenance therapy on brain volume: randomized (dis)continuation after remission of a first psychotic episode. - HAMLETT MRI

niversitair Medisch Centrum Groningen0 个研究点目标入组 225 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
225

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Inclusion criteria for FEP patients:
  • 1. The participant has had a first episode of psychosis and uses antipsychotic
  • medication.
  • 2. Psychotic symptoms are in remission for 3-6 months with an antipsychotic.
  • 3. Age 18-60 years.
  • 4. The participant understands the study and is able to provide written
  • informed consent.
  • 5. HAMLETT is the only medical-scientific medication study in which the patient
  • participates.
  • 6. Sufficient command of the Dutch language.
  • Inclusion criteria for healthy controls for OCT:
  • 1. Age 18-60 years.
  • 2. The participant understands the study and is able to provide written
  • informed consent.

排除标准

  • Exclusion criteria for FEP patients:
  • 1. Dangerous or harmful behaviour occurred during the psychosis
  • 2. Coercive treatment (based on judicial ruling)
  • 3. The refusal to be informed of structural brain abnormalities that could be
  • detected during the experiment
  • 4. MRI contra-indications, e.g. Ferrous objects in or around the body, or
  • claustrophobia
  • 5. Pregnancy
  • Exclusion criteria for healthy controls for the OCT-scan:
  • 1. (History of) diagnosed psychiatric disorders
  • 2. (History of) psychotropic medication use
  • 3. (History of) neurological diseases that may affect the brain
  • 4. (History of) substance abuse
  • 5. (History of) ophthalmological disorders, as determined with the
  • questionnaire on eye health ('Vragenlijst ooggezondheid*)
  • 6. (History of) systemic and autoimmune diseases that may affect the eye or
  • optic nerve, e.g. diabetes, glaucoma or refractory arterial hypertension
  • 7. First-degree family member with glaucoma

研究者

相似试验